In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

Biosimilar medicines are available in therapy areas… 16 December 2020
Biosimilar medicines: competition, sustainability… 30 October 2019 Medicines for Europe welcomes 5th European Commission Stakeholder event on…
Medicines for Europe members publish disclosure of… 22 June 2018 Medicines for Europe is committed to bringing accessible, high quality…
Interview: Medicines for Europe Reports on EU… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…